Last edition
News about "IAVI"
Biofabri and Bharat Biotech Sign Technology Transfer Deal for MTBVAC
Biofabri and Bharat Biotech have entered into a technology transfer agreement to enable end-to-end manufacturing of the MTBVAC tuberculosis vaccine candidate, supporting global efforts to expand access to new TB prevention options, particularly in high-burden, low- and middle-income countries.
IAVI | 24/12/2025 | By News Bureau | 109
Through a novel public-private partnership, IAVI, Minapharm and ProBioGen will work together to bolster the innovation ecosystem on the continent and enable sustainable access to urgently-needed products.
IAVI | 13/10/2025 | By Dineshwori | 133
Global diseases treatment with mRNA to be researched by Moderna and IAVI together
Moderna and IAVI, a nonprofit scientific research organization, are teaming up to use mRNA to develop new therapies for a range of diseases like HIV / AIDS, Tuberculosis, anti-microbial-resistant enteric infection and COVID-19.
IAVI | 12/04/2022 | By Sudeep Soparkar | 671
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy